Ioffe; Ella
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ioffe; Ella.The latest application filed is for "human antibodies to pd-l1".
- Ioffe; Ella - Bronx NY
- Ioffe; Ella - New York NY
| Patent | Date |
|---|---|
| Human Antibodies To Pd-l1 App 20210380702 - Papadopoulos; Nicholas J. ; et al. | 2021-12-09 |
| Novel Il10 Agonists And Methods Of Use Thereof App 20210355184 - DAI; Jie ; et al. | 2021-11-18 |
| Human antibodies to PD-L1 Grant 11,117,970 - Papadopoulos , et al. September 14, 2 | 2021-09-14 |
| Non-human Animals Having A Humanized Cluster Of Differentiation 47 Gene App 20210161112 - Gurer; Cagan ; et al. | 2021-06-03 |
| Method of using mouse having a humanized cluster of differentiation 47 gene Grant 10,939,673 - Gurer , et al. March 9, 2 | 2021-03-09 |
| Anti-CTLA-4 Antibodies and Uses Thereof App 20210040232 - HERMANN; Aynur ; et al. | 2021-02-11 |
| Anti-CTLA-4 antibodies and uses thereof Grant 10,844,137 - Hermann , et al. November 24, 2 | 2020-11-24 |
| Human Antibodies To Pd-1 App 20200330794 - Papadopoulos; Nicholas J. ; et al. | 2020-10-22 |
| Human antibodies to PD-1 Grant 10,737,113 - Papadopoulos , et al. A | 2020-08-11 |
| Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody Grant 10,532,096 - Ioffe , et al. Ja | 2020-01-14 |
| Anti-lag3 Antibodies And Uses Thereof App 20190284277 - ULLMAN; Erica ; et al. | 2019-09-19 |
| Anti-LAG3 antibodies and uses thereof Grant 10,358,495 - Ullman , et al. | 2019-07-23 |
| Anti-CTLA-4 Antibodies and Uses Thereof App 20190048096 - HERMANN; Aynur ; et al. | 2019-02-14 |
| Non-human Animals Having A Humanized Cluster Of Differentiation 47 Gene App 20180249689 - Gurer; Cagan ; et al. | 2018-09-06 |
| Methods And Compositions Comprising A Combination Of A Vegf Antagonist And An Anti-ctla-4 Antibody App 20180236070 - IOFFE; Ella ; et al. | 2018-08-23 |
| Non-human animals having a humanized cluster of differentiation 47 gene Grant 10,015,953 - Gurer , et al. July 10, 2 | 2018-07-10 |
| Human Antibodies To Pd-1 App 20180185668 - PAPADOPOULOS; Nicholas J. ; et al. | 2018-07-05 |
| Human Antibodies To Pd-l1 App 20180186883 - PAPADOPOULOS; Nicholas J. ; et al. | 2018-07-05 |
| Human antibodies to PD-1 Grant 9,987,500 - Papadopoulos , et al. June 5, 2 | 2018-06-05 |
| Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody Grant 9,968,674 - Ioffe , et al. May 15, 2 | 2018-05-15 |
| Human antibodies to PD-L1 Grant 9,938,345 - Papadopoulos , et al. April 10, 2 | 2018-04-10 |
| Anti-LAG3 Antibodies and Uses Thereof App 20170101472 - ULLMAN; Erica ; et al. | 2017-04-13 |
| Non-human Animals Having A Humanized Cluster Of Differentiation 47 Gene App 20160345549 - Gurer; Cagan ; et al. | 2016-12-01 |
| Methods And Compositions Comprising A Combination Of A Vegf Antagonist And An Anti-ctla-4 Antibody App 20160243225 - IOFFE; Ella ; et al. | 2016-08-25 |
| Non-human Animals Having A Humanized Cluster Of Differentiation 47 Gene App 20160157470 - Gurer; Cagan ; et al. | 2016-06-09 |
| Human Antibodies to PD-1 App 20150203579 - Papadopoulos; Nicholas J. ; et al. | 2015-07-23 |
| Human Antibodies to PD-L1 App 20150203580 - Papadopoulos; Nicholas J. ; et al. | 2015-07-23 |
| Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof Grant 7,812,137 - Friedman , et al. October 12, 2 | 2010-10-12 |
| Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof App 20070048836 - Friedman; Jeffrey M. ; et al. | 2007-03-01 |
| Oligonucleotides of the OB-R isoforms and methods of diagnosing body weight Grant 7,148,004 - Friedman , et al. December 12, 2 | 2006-12-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 